NewsRx

Search our medical news database

Helm Capital Group, Inc.

Distribution rights to Glyco OTC pharmaceutical products acquired

Published in Fitness and Wellness Business Week, February 9th, 2005

Helm Capital Group, Inc., announced that it had acquired worldwide distribution rights to all of the over-the-counter pharmaceutical products developed by GlycoBioSciences, Inc.

Glyco is a research and development company, dedicated to human wellness and sexual health. The distribution rights are exclusive, except that Glyco retained the right to market and sell products under its own name and for its own account.

Glyco currently has two over-the-counter products that are ready for immediate distribution and sale.

One product is a female intimate lubricant that has been developed and formulated by Glyco to assist women who are...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Fitness and Wellness Business Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook